CXCR2 and neoplasm: This observation led to the design of CAR T cells expressing CXCR1 or CXCR2, that demonstrate enhanced migration to and persistence in the tumor, which correlates with complete tumor regression and long-lasting immunologic memory in models of numerous aggressive tumors.